The British Journal of Ophthalmology

Multiple age-related eye diseases linked to severe vision loss

Compared with one age-related eye disease, two were associated with 1.93 times the risk of severe vision loss, and three with 2.54 times the risk.

Paper by Sooyeon Choe, Xi Chen, Dong Young Park, +3 more authorsYoung Kook Kim · Ajou University Hospital · Seoul National University

Our read

Populations
Studied:
Cohort study of national health screening participants, against patients with one AROD
What changed:
Risk of severe vision loss increased 1.93-fold with a second age-related eye disease compared with one
The catch:
Only 595 individuals developed two or more conditions, leaving estimates imprecise
Why it’s aging research:
It measures an outcome that worsens with age.

Editor of record: Boris Djordjevic · AgingResearch.News

Follow @agingbrief

Among 0.5 million participants in a Korean national health screening cohort, an observational study linked multiple age-related eye diseases to a higher risk of severe vision loss. Researchers analyzed records from 2004 to 2019. They identified newly diagnosed eye diseases using diagnostic codes and medication prescriptions. They identified severe vision loss through health check-ups and disability registration records.

The conditions were glaucoma, degeneration affecting areas at the back of the eye, and diabetes-related eye complications. Overall, 595 participants developed two or more conditions. Having more conditions remained associated with higher risk after researchers accounted for demographic factors, behaviors and other illnesses.

Why it matters

Age-related eye diseases often coexist as people grow older. The authors emphasized the need for integrated eye care, including efforts to prevent additional eye diseases.

Caveats

This observational study cannot establish that additional eye diseases caused severe vision loss. The estimate for three conditions was especially imprecise, and the abstract does not report absolute risks.

Comments

Be the first to comment.